|Watson Pharmaceuticals, Inc. (Watson) is an integrated global pharmaceutical company engaged in the development, manufacturing, marketing, sale and distribution of generic and brand pharmaceutical products. The Company operates in three segments: Global Generics, Global Brands and Distribution. It operates in international markets, including Western Europe, Canada, Australasia, Asia, South America and South Africa with its primary market being the United States. As of December 31, 2011, the Company marketed approximately 160 generic pharmaceutical product families and approximately 30 brand pharmaceutical product families in the United States and a number of product families internationally through its Global Generics and Global Brands Divisions, respectively. In October 2012, the Company sold its Rugby over-the-counter (OTC) pharmaceutical products and trademarks. In October 2012, the Company acquired the Actavis Group.